Caris Life Sciences, Inc. (CAI)
NASDAQ·Healthcare·Biotechnology
$17.97
-0.17%
Mkt Cap $4.79B
Analyst Ratings
Buy
7
Hold
2
Sell
0
Price Target (7 analysts)
$28.75
Range $21.00 – $38.00
Implied Upside
+60.0%
Consensus $28.75 vs current $17.97
NASDAQ·Healthcare·Biotechnology
$17.97
-0.17%
Mkt Cap $4.79B
Buy
7
Hold
2
Sell
0
Price Target (7 analysts)
$28.75
Range $21.00 – $38.00
+60.0%
Consensus $28.75 vs current $17.97